Literature DB >> 20654728

Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.

Sara Rodríguez-Enríquez1, Liliana Carreño-Fuentes, Juan Carlos Gallardo-Pérez, Emma Saavedra, Héctor Quezada, Alicia Vega, Alvaro Marín-Hernández, Viridiana Olín-Sandoval, M Eugenia Torres-Márquez, Rafael Moreno-Sánchez.   

Abstract

It has been assumed that oxidative phosphorylation (OxPhos) in solid tumors is severely reduced due to cytochrome c oxidase substrate restriction, although the measured extracellular oxygen concentration in hypoxic areas seems not limiting for this activity. To identify alternative hypoxia-induced OxPhos depressing mechanisms, an integral analysis of transcription, translation, enzyme activities and pathway fluxes was performed on glycolysis and OxPhos in HeLa and MCF-7 carcinomas. In both neoplasias exposed to hypoxia, an early transcriptional response was observed after 8h (two times increased glycolysis-related mRNA synthesis promoted by increased HIF-1alpha levels). However, major metabolic remodeling was observed only after 24h hypoxia: increased glycolytic protein content (1-5-times), enzyme activities (2-times) and fluxes (4-6-times). Interestingly, in MCF-7 cells, 24h hypoxia decreased OxPhos flux (4-6-fold), and 2-oxoglutarate dehydrogenase and glutaminase activities (3-fold), with no changes in respiratory complexes I and IV activities. In contrast, 24h hypoxia did not significantly affect HeLa OxPhos flux; neither mitochondria related mRNAs, protein contents or enzyme activities, although the enhanced glycolysis became the main ATP supplier. Thus, prolonged hypoxia (a) targeted some mitochondrial enzymes in MCF-7 but not in HeLa cells, and (b) induced a transition from mitochondrial towards a glycolytic-dependent energy metabolism in both MCF-7 and HeLa carcinomas. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20654728     DOI: 10.1016/j.biocel.2010.07.010

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  36 in total

1.  BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose.

Authors:  Federico Lucantoni; Heiko Düssmann; Irene Llorente-Folch; Jochen H M Prehn
Journal:  Oncotarget       Date:  2018-05-25

2.  Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes.

Authors:  Austin E Gillen; Heather M Brechbuhl; Tomomi M Yamamoto; Enos Kline; Manoj M Pillai; Jay R Hesselberth; Peter Kabos
Journal:  Mol Cancer Res       Date:  2017-09-14       Impact factor: 5.852

3.  Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells.

Authors:  David N DeHart; Diana Fang; Kareem Heslop; Li Li; John J Lemasters; Eduardo N Maldonado
Journal:  Biochem Pharmacol       Date:  2017-12-28       Impact factor: 5.858

4.  The metabolic interaction of cancer cells and fibroblasts - coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide.

Authors:  Irina N Druzhkova; Marina V Shirmanova; Maria M Lukina; Varvara V Dudenkova; Nataliya M Mishina; Elena V Zagaynova
Journal:  Cell Cycle       Date:  2016-05-02       Impact factor: 4.534

Review 5.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

6.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).

Authors:  Jie Zheng
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

7.  Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture.

Authors:  İrem Bayar; Ayşegül Bildik
Journal:  Cytotechnology       Date:  2021-02-20       Impact factor: 2.058

8.  Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.

Authors:  Rossana Domenis; Elena Bisetto; Davide Rossi; Marina Comelli; Irene Mavelli
Journal:  Int J Mol Sci       Date:  2012-02-10       Impact factor: 6.208

Review 9.  Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.

Authors:  Miljana Nenkov; Yunxia Ma; Nikolaus Gaßler; Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

10.  Regulatory Mechanisms and Functional Roles of Hypoxia-Induced Long Non-Coding RNA MTORT1 in Breast Cancer Cells.

Authors:  Yi-Chun Cheng; Li-Yu Su; Li-Han Chen; Tzu-Pin Lu; Eric Y Chuang; Mong-Hsun Tsai; Li-Ling Chuang; Liang-Chuan Lai
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.